◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › WELL

Welltower Inc (WELL) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

REAL ESTATE · Health Care REITs · DATA UPDATED 2026-07-12

Welltower Inc (WELL) operates in the Health Care REITs industry and is headquartered in Toledo, United States with about 712 employees. Its market capitalization is roughly $178 billion. In the fiscal year ended 2025-12-31, WELL reported $10.7B in revenue and $937M in net income.

Welltower Inc., an S&P 500 company, is positioned at the center of the silver economy, focusing on rental housing for aging seniors across the United States, United Kingdom, and Canada.

Interactive charts & full statements → Open the WELL valuation workbench →

WELL Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$11.6B$10.7B$7.9B$6.5B$5.8B$4.7B$4.6B$5.1B$4.7B$4.3B$4.3B$3.8B$3.3B$2.9B$1.8B$1.3B$571M$523M$526M$429M$288M
Gross Profit$4.5B$4.2B$3.0B$2.5B$2.2B$1.9B$2.0B$2.4B$2.2B$2.2B$2.4B$2.2B$1.9B$1.7B$1.2B$927M$494M$481M$484M$396M$287M
Gross Margin %38.9%39.2%38.5%39.1%38.4%41.1%43.4%47.3%47.9%51.5%55.9%57.8%57.9%58.1%68.4%71.2%86.4%91.9%91.9%92.2%99.6%
Operating Income (EBIT)$535M$355M$1.1B$940M$746M$763M$727M$1.2B$1.2B$1.1B$1.3B$1.2B$945M$694M$601M$461M$244M$267M$292M$234M$178M
Operating Margin %4.6%3.3%14.6%14.5%12.9%16.2%15.9%24.3%24.9%25.8%30.8%32.4%28.3%24.1%33.4%35.4%42.7%51.0%55.5%54.6%61.9%
Net Income$1.4B$937M$952M$340M$141M$336M$979M$1.2B$805M$523M$1.1B$884M$512M$145M$297M$218M$129M$193M$283M$138M$103M
Net Margin %12.2%8.8%12.1%5.2%2.4%7.1%21.3%24.2%17.2%12.2%25.4%23.0%15.3%5.0%16.5%16.7%22.5%36.9%53.8%32.2%35.6%
EBITDA$2.6B$2.3B$2.8B$2.4B$2.0B$1.7B$1.5B$2.1B$1.9B$1.7B$2.1B$2.0B$1.7B$1.4B$1.1B$841M$387M$422M$449M$394M$279M
Earnings Per Share (EPS)$2.00$1.38$1.56$0.66$0.30$0.79$2.35$3.05$2.15$1.42$2.99$2.53$1.66$0.52$1.32$1.25$1.00$1.69$3.00$1.74$1.66
Shares Outstanding (M)726M680M609M519M465M427M417M404M375M369M360M349M308M279M226M174M128M115M94M79M62M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

WELL Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue$3.3B$3.1B$2.6B$2.5B$2.4B$2.2B$2.0B$1.8B
Gross Profit$1.2B$1.2B$1.1B$1.0B$926M$810M$798M$681M
Gross Margin %37.8%38.3%40.0%39.8%38.8%36.5%39.7%38.0%
Operating Income (EBIT)$558M($944M)$477M$443M$379M$281M$312M$239M
Operating Margin %16.9%-30.1%18.1%17.6%15.8%12.7%15.5%13.3%
Net Income$729M$96M$281M$302M$258M$120M$450M$255M
Net Margin %22.0%3.1%10.7%12.0%10.8%5.4%22.4%14.2%
EBITDA$1.2B($459M)$979M$948M$843M$748M$742M$621M
Earnings Per Share (EPS)$1.00$0.14$0.41$0.45$0.39$0.19$0.73$0.42
Shares Outstanding (M)726M710M685M668M654M634M618M605M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

WELL Free Cash Flow History

Cash flowTTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Cash from Operations (CFO)$3.0B$2.9B$2.3B$1.6B$1.3B$1.3B$1.4B$1.5B$1.6B$1.4B$1.6B$1.4B$1.1B$988M$818M$588M$365M$381M$336M$264M$216M
Capital Expenditures (CapEx)$411M$34M$58M$51M$30M$19M$17M$15M$8M$13M$17M$9M$7M$7M$10M$4.9B$2.1B$640M$1.1B$631M$429M
Free Cash Flow (FCF)$2.5B$2.8B$2.2B$1.6B$1.3B$1.3B$1.3B$1.5B$1.6B$1.4B$1.6B$1.4B$1.1B$982M$808M($4.3B)($1.7B)($259M)($737M)($367M)($213M)
FCF Margin %21.9%26.7%28.0%23.9%22.5%26.7%29.4%29.8%33.7%33.1%38.1%35.5%33.9%34.1%44.9%-332.6%-302.8%-49.5%-139.9%-85.5%-73.8%
Dividends Paid$2.0B$1.9B$1.5B$1.3B$1.1B$1.0B$1.1B$1.4B$1.3B$1.3B$1.3B$1.2B$1.0B$906M$722M$544M$370M$334M$277M$208M$200M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

WELL Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Cash from Operations (CFO)$670M$654M$858M$770M$599M$559M$685M$605M
Capital Expenditures (CapEx)$388M$7M$6M$9M$12M$14M$16M$14M
Free Cash Flow (FCF)$282M$647M$852M$761M$587M$545M$669M$591M
FCF Margin %8.5%20.6%32.4%30.3%24.6%24.6%33.3%33.0%
Dividends Paid$520M$510M$497M$439M$432M$418M$409M$366M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

WELL Balance Sheet History

Balance sheet2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Assets$67.2B$67.3B$51.0B$44.0B$37.9B$34.9B$32.5B$33.4B$30.3B$27.9B$28.9B$29.0B$25.0B$23.1B$19.5B$14.9B$9.5B$6.4B$6.2B$5.2B$4.3B
Cash & Cash Equivalents$4.7B$5.0B$3.5B$2.0B$632M$269M$1.5B$285M$215M$244M$419M$361M$474M$159M$1.0B$163M$132M$35M$23M$30M$36M
Total Liabilities$22.3B$24.1B$18.5B$17.6B$16.5B$15.9B$15.3B$16.4B$14.3B$12.6B$13.2B$13.7B$11.5B$11.3B$9.0B$7.6B$4.7B$2.6B$3.0B$2.8B$2.3B
Total Debt (Short + Long-Term)$17.9B$19.2B$15.5B$17.5B$27.4B$14.1B$14.2B$14.9B$13.3B$11.7B$12.4B$13.0B$21.6B$10.7B$8.5B$7.6B$4.5B$2.4B$2.8B$2.6B$2.1B
Total Shareholders' Equity$43.8B$42.1B$32.0B$25.4B$21.4B$17.6B$17.2B$15.5B$14.6B$14.4B$14.8B$14.6B$13.6B$11.4B$10.3B$7.1B$4.6B$3.8B$3.2B$2.4B$2.0B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive WELL viewer.

Other Companies in Health Care REITs

← WECAll stocksWEN →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.